236 related articles for article (PubMed ID: 38174191)
1. Diagnosis and Treatment of Liver Disease: Current Trends and Future Directions.
Wazir H; Abid M; Essani B; Saeed H; Ahmad Khan M; Nasrullah F; Qadeer U; Khalid A; Varrassi G; Muzammil MA; Maryam A; Syed ARS; Shah AA; Kinger S; Ullah F
Cureus; 2023 Dec; 15(12):e49920. PubMed ID: 38174191
[TBL] [Abstract][Full Text] [Related]
2. Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease.
Sharma N; Chakole S; Wandile B
Cureus; 2023 Oct; 15(10):e46946. PubMed ID: 38021670
[TBL] [Abstract][Full Text] [Related]
3. Overview of Complications in Cirrhosis.
Premkumar M; Anand AC
J Clin Exp Hepatol; 2022; 12(4):1150-1174. PubMed ID: 35814522
[TBL] [Abstract][Full Text] [Related]
4. Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches.
Arvanitakis K; Papadakos SP; Lekakis V; Koufakis T; Lempesis IG; Papantoniou E; Kalopitas G; Georgakopoulou VE; Stergiou IE; Theocharis S; Germanidis G
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834153
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention.
Tacke F; Weiskirchen R
Ann Transl Med; 2021 Apr; 9(8):729. PubMed ID: 33987427
[TBL] [Abstract][Full Text] [Related]
6. Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?
Plaz Torres MC; Bodini G; Furnari M; Marabotto E; Zentilin P; Strazzabosco M; Giannini EG
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486355
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
Hochreuter MY; Dall M; Treebak JT; Barrès R
Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications.
Wong SW; Ting YW; Chan WK
JGH Open; 2018 Oct; 2(5):235-241. PubMed ID: 30483595
[TBL] [Abstract][Full Text] [Related]
9. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
[TBL] [Abstract][Full Text] [Related]
10. Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease.
Suresh D; Srinivas AN; Kumar DP
Front Oncol; 2020; 10():601710. PubMed ID: 33330100
[TBL] [Abstract][Full Text] [Related]
11. Current treatment of non-alcoholic fatty liver disease.
Paternostro R; Trauner M
J Intern Med; 2022 Aug; 292(2):190-204. PubMed ID: 35796150
[TBL] [Abstract][Full Text] [Related]
12. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in non-alcohol fatty liver disease - changing trends and specific challenges.
Berkan-Kawińska A; Piekarska A
Curr Med Res Opin; 2020 Feb; 36(2):235-243. PubMed ID: 31631714
[No Abstract] [Full Text] [Related]
14. Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes.
Ito T; Nguyen MH
J Hepatocell Carcinoma; 2023; 10():413-428. PubMed ID: 36926055
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease - current status and future directions.
Demir M; Lang S; Steffen HM
J Dig Dis; 2015 Oct; 16(10):541-57. PubMed ID: 26406351
[TBL] [Abstract][Full Text] [Related]
16. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
[TBL] [Abstract][Full Text] [Related]
17. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements.
Perisetti A; Goyal H; Yendala R; Thandassery RB; Giorgakis E
World J Gastroenterol; 2021 Jun; 27(24):3466-3482. PubMed ID: 34239263
[TBL] [Abstract][Full Text] [Related]
18. Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer - nationwide population-based study.
Haider MB; Al Sbihi A; Chaudhary AJ; Haider SM; Edhi AI
World J Hepatol; 2022 Sep; 14(9):1804-1816. PubMed ID: 36185720
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges.
Teng YX; Xie S; Guo PP; Deng ZJ; Zhang ZY; Gao W; Zhang WG; Zhong JH
J Clin Transl Hepatol; 2022 Oct; 10(5):955-964. PubMed ID: 36304509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
